Anbio Biotechnology (NNNN) Total Current Liabilities (2023 - 2025)
Historic Total Current Liabilities for Anbio Biotechnology (NNNN) over the last 3 years, with Q2 2025 value amounting to $131.1 billion.
- Anbio Biotechnology's Total Current Liabilities changed N/A to $131.1 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $131.1 billion, marking a year-over-year change of. This contributed to the annual value of $1730.2 billion for FY2024, which is 17423247406.4% up from last year.
- Per Anbio Biotechnology's latest filing, its Total Current Liabilities stood at $131.1 billion for Q2 2025.
- In the past 5 years, Anbio Biotechnology's Total Current Liabilities registered a high of $1730.2 billion during Q4 2024, and its lowest value of $993060.0 during Q4 2023.
- Its 3-year average for Total Current Liabilities is $620.5 billion, with a median of $131.1 billion in 2025.
- Examining YoY changes over the last 5 years, Anbio Biotechnology's Total Current Liabilities showed a top increase of 17423247406.4% in 2024 and a maximum decrease of 17423247406.4% in 2024.
- Anbio Biotechnology's Total Current Liabilities (Quarter) stood at $993060.0 in 2023, then soared by 174232474.06% to $1730.2 billion in 2024, then tumbled by 92.42% to $131.1 billion in 2025.
- Its last three reported values are $131.1 billion in Q2 2025, $1730.2 billion for Q4 2024, and $993060.0 during Q4 2023.